Humana Inc. (NYSE:HUM) Holdings Decreased by Canada Pension Plan Investment Board

Canada Pension Plan Investment Board reduced its holdings in Humana Inc. (NYSE:HUM) by 51.8% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 188,853 shares of the insurance provider’s stock after selling 203,326 shares during the period. Canada Pension Plan Investment Board owned about 0.16% of Humana worth $47,914,000 at the end of the most recent reporting period.

Other hedge funds have also recently bought and sold shares of the company. Global Endowment Management LP grew its holdings in shares of Humana by 7.7% during the 4th quarter. Global Endowment Management LP now owns 1,827 shares of the insurance provider’s stock valued at $464,000 after acquiring an additional 131 shares in the last quarter. Insigneo Advisory Services LLC boosted its position in Humana by 17.3% during the fourth quarter. Insigneo Advisory Services LLC now owns 1,360 shares of the insurance provider’s stock worth $345,000 after purchasing an additional 201 shares during the period. Dodge & Cox grew its holdings in Humana by 106.7% during the fourth quarter. Dodge & Cox now owns 10,198,040 shares of the insurance provider’s stock valued at $2,587,345,000 after purchasing an additional 5,264,045 shares during the last quarter. Adams Wealth Management lifted its stake in shares of Humana by 24.3% in the fourth quarter. Adams Wealth Management now owns 9,717 shares of the insurance provider’s stock worth $2,465,000 after buying an additional 1,899 shares during the last quarter. Finally, AGP Franklin LLC bought a new stake in shares of Humana during the 4th quarter worth $1,506,000. 92.38% of the stock is owned by hedge funds and other institutional investors.

Analyst Ratings Changes

A number of equities research analysts have issued reports on the stock. Royal Bank of Canada restated an “outperform” rating and set a $283.00 price target on shares of Humana in a report on Wednesday, February 12th. Barclays upped their price target on Humana from $270.00 to $322.00 and gave the stock an “equal weight” rating in a report on Friday, April 11th. Piper Sandler boosted their target price on shares of Humana from $270.00 to $288.00 and gave the stock a “neutral” rating in a research report on Wednesday, January 15th. Cantor Fitzgerald restated a “neutral” rating and issued a $290.00 price target on shares of Humana in a research report on Wednesday, February 12th. Finally, Guggenheim assumed coverage on shares of Humana in a research note on Wednesday, April 9th. They issued a “buy” rating and a $326.00 target price for the company. Seventeen equities research analysts have rated the stock with a hold rating and seven have assigned a buy rating to the stock. According to data from MarketBeat, the company has a consensus rating of “Hold” and a consensus price target of $284.90.

Humana Price Performance

Shares of Humana stock opened at $264.41 on Friday. Humana Inc. has a 1-year low of $213.31 and a 1-year high of $406.46. The firm’s 50-day moving average price is $265.90 and its two-hundred day moving average price is $269.86. The company has a current ratio of 1.76, a quick ratio of 1.76 and a debt-to-equity ratio of 0.68. The stock has a market capitalization of $31.91 billion, a price-to-earnings ratio of 26.57, a P/E/G ratio of 2.05 and a beta of 0.62.

Humana (NYSE:HUM) last posted its quarterly earnings data on Tuesday, February 11th. The insurance provider reported ($2.16) EPS for the quarter, topping analysts’ consensus estimates of ($2.26) by $0.10. Humana had a return on equity of 11.70% and a net margin of 1.02%. On average, equities analysts predict that Humana Inc. will post 16.47 earnings per share for the current fiscal year.

Humana Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Friday, July 25th. Investors of record on Friday, June 27th will be issued a $0.885 dividend. This represents a $3.54 dividend on an annualized basis and a dividend yield of 1.34%. Humana’s dividend payout ratio is currently 35.58%.

About Humana

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.